Co-immunization of BALB/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response (Q45453606)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2005

Language	Label	Description	Also known as
English	Co-immunization of BALB/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response	scientific article published in August 2005

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Co-immunization of BALB/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response (English)

1 reference

Europe PubMed Central

14 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Chang-Fa Fan

1

1 reference

Europe PubMed Central

14 December 2017

Xing-Guo Mei

2

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

14 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

14 December 2017

23

1 reference

Europe PubMed Central

14 December 2017

35

1 reference

Europe PubMed Central

14 December 2017

4453-4461

1 reference

Europe PubMed Central

14 December 2017

Vaccine strategies: selective elicitation of cellular or humoral immunity?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Reduction of respiratory syncytial virus titer in the lungs of mice after intranasal immunization with a chimeric peptide consisting of a single CTL epitope linked to a fusion peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Structural Properties of Chimeric Peptides Containing a T-cell Epitope Linked to a Fusion Peptide and their Importance for in Vivo Induction of Cytotoxic T-cell Responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Crystal structure of the protein disulfide bond isomerase, DsbC, from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

The uncharged surface features surrounding the active site of Escherichia coli DsbA are conserved and are implicated in peptide binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Fusion of DsbA to the N-terminus of CTL chimeric epitope, F/M2:81-95, of respiratory syncytial virus prolongs protein- and virus-specific CTL responses in Balb/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

A new approach for measurement of cytotoxicity using colorimetric assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

A new method for the preparation of human parathyroid hormone 1-34 peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Cytokine pattern is solely influenced by priming vaccine but immunity and disease by both priming and boosting vaccines in mice challenged with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Immunity to and frequency of reinfection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Structural features of a chimeric peptide inducing cytotoxic T lymphocyte responses in saline

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

The optimization of helper T lymphocyte (HTL) function in vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.044

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.03.044

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45453606&oldid=2076962717"